INVESTORS

Press Releases

Science Article About the Quest to Cure HBV Brings Context to Precision BioSciences Collaboration with Gilead

November 30, 2018 at 6:00 AM EST
PDF Version

Precision BioSciences is pleased to be part of this important feature story from Science Magazine:

Forgotten No More – A long-overlooked scourge of millions, hepatitis B is in the crosshairs at last

You can read more about the collaboration between Gilead and Precision to develop therapies against hepatitis B virus using ARCUS genome editing here.

View Document

Contacts

Precision BioSciences
Heather King, +1-919-314-5512
heather.king@precisionbiosciences.com

Investors

Investor Tools